drugset
drugset / Trial / NCT04183686

A Study to Examine the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-1014-6470 in Healthy Subjects

NCT04183686 ↗

Phase 1 Completed 88 enrolled Idorsia Pharmaceuticals Ltd.
RandomizedSequentialQuadruple-blindOther

Summary

A study to examine the safety, tolerability, and pharmacokinetics of single- and multiple-ascending doses of ACT-1014-6470 in healthy subjects

Timeline

Start
2019-11-25
Primary completion
2020-03-15
Completion
2020-03-15

Drugs

EvaluationDrugModalityDoseRoute
Subject ACT-1014-6470 Unknown — Oral

Indications

No indication recorded.